https://www.selleckchem.com/products/atn-161.html
iruses. Copyright © 2020, Archives of Razi Institute. Published by Kowsar.BACKGROUND The 21-gene recurrence score (RS) assay has been recommended by major guidelines for treatment decision in hormone receptor (HR)-positive early breast cancer (EBC). However, the genomic assay is not accessible and affordable worldwide. Alternatively, an increasing number of studies have shown that traditional immunohistochemistry (IHC) can partially or even completely replace the role of the 21-gene genomic assay. Here, we developed and validated a pred
Like
Comment
Share
